ABT - Conference and earnings call announcements

Abbott, in collaboration with Real Madrid, will host free selection events combining soccer and health education to identify the second annual 'Abbott Dream Team'All participants will receive sports nutrition guidance from Abbott experts and take part in on-field development sessions led by Real Madrid coachesThe 16 selected male and female 'Abbott Dream Team' members, ages 18–19, will travel to Spain on an all‑expenses‑paid trip to train at Real Madrid's official facilitiesLearn more and register at AbbottDreamTeam.comABBOTT PARK, Ill., March 11, 2026 /PRNewswire/ -- Abbott (NYSE:ABT) announced today the launch of the second year of the 'Abbott Dream Team,' encouraging young soccer players

Leadership appointment strengthens strategic and development capabilities FDA Type D Meeting provides additional guidance for advancing the clinical development of tecarfarin Collaboration Agreement with Abbott (NYSE:ABT) validates the need for new anticoagulation options Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing therapeutics for patients with cardiovascular disease, today reported its financial results for the first quarter ended March 31, 2025, and provided an update on the strategic focus of the company and clinical development of tecarfarin. "In the first quarter of 2025, Cadrenal continued to build on the momentum we achieved during 2024," sa

Enrollment completed ahead of schedule in the global IDE for Abbott's Volt™ PFA SystemGlobal FOCALFLEX trial now underway for Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™Advisor™ HD Grid X Mapping Catheter, Sensor Enabled™, receives U.S. Food and Drug Administration clearance, begins commercial launchABBOTT PARK, Ill., Oct. 10, 2024 /PRNewswire/ -- Abbott (NYSE:ABT) announced today it has achieved new major milestones to support the company's growing suite of pulsed field ablation (PFA) solutions in electrophysiology: early completion of enrollment in the VOLT-AF IDE Study supporting the Volt™ PFA System, and the launch of the FOCALFLEX trial to assess the company's TactiFlex™

Eight health centers across the U.S. participate in Innovation Incubator to find new ways to integrate healthy food into clinical careNow in its second year, the goal of the Innovation Incubator is to share what works with 1,400 health centers providing affordable care for 31+ millionABBOTT PARK, Ill. and BETHESDA, Md., June 20, 2024 /PRNewswire/ -- The global healthcare company Abbott (NYSE:ABT) and the National Association of Community Health Centers (NACHC) have joined together to increase access to healthy foods and improve health through the Innovation Incubator initiative. Eight community health centers have been selected to receive funding, expert guidance and training to design and t

ABBOTT PARK, Ill., Dec. 18, 2023 /PRNewswire/ -- Abbott (NYSE:ABT) will present at the 42nd annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 9, 2024. Robert B. Ford, chairman and chief executive officer, will present at 11 a.m. Central time. A live webcast of the presentation will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. About Abbott:Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues s

ABBOTT PARK, Ill., Dec. 20, 2022 /PRNewswire/ -- Abbott (NYSE:ABT) will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 10, 2023. Robert B. Ford, chairman and chief executive officer, will present at 11 a.m. Central time. A live webcast of the presentation will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the presentation will be available later that day. About Abbott:Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical dev

ABBOTT PARK, Ill., Dec. 21, 2021 /PRNewswire/ -- Abbott (NYSE:ABT) will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 11, 2022. Robert B. Ford, chairman and chief executive officer, will present at 8 a.m. Central time. A live webcast of the presentation will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the presentation will be available later that day. About Abbott:Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, m

ABBOTT PARK, Ill., June 22, 2021 /PRNewswire/ -- High school students who complete Abbott's award-winning summer internship program are now eligible to receive college credit for the experience in a first-of-its-kind effort that can serve as a model for other companies to support STEM education. Abbott's program, which has provided diverse teenagers across the U.S. with opportunities in the STEM fields for nearly a decade, is the first high school STEM internship that the American Council on Education (ACE) has recommended for college credit. Students who complete the program

ABBOTT PARK, Ill., Dec. 18, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) will present virtually at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12, 2021. Robert B. Ford, president and chief executive officer, will present at 9 a.m. Central time. A live webcast of the presentation will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the presentation will be available the next day. About Abbott:Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics